Lawsuit Overview
October 22, 2013 (Shareholders Foundation) - An investor who holds shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) filed a lawsuit against directors of Peregrine Pharmaceuticals in connection with allegedly excessive compensation. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:PPHM stockholders by agreeing to exce...
You must register (for free) or login to view the entire case.